AB 2821
10 links on this map: who funds them, what they touched, and who lobbied on it. Select anyone to move the map to them.
Start with
and connect to
Browse all held record sources
Zoom to read. Drag to explore. Select a connection.
Every link on this map
The same connections as a table, with the reason each one is here.
| Mike Feuer | Sponsors | Mike Feuer sponsored AB 2821. | None |
| Amylin Pharmaceuticals, Inc. | Lobbied on it | Amylin Pharmaceuticals, Inc. named AB 2821 in 4 lobbying reports. | 4 reports |
| Astrazeneca Pharmaceuticals, LP | Lobbied on it | Astrazeneca Pharmaceuticals, LP named AB 2821 in 4 lobbying reports. | 4 reports |
| Boehringer Ingelheim Pharmaceuticals, Inc. | Lobbied on it | Boehringer Ingelheim Pharmaceuticals, Inc. named AB 2821 in 4 lobbying reports. | 4 reports |
| California Wic Association | Lobbied on it | California Wic Association named AB 2821 in 4 lobbying reports. | 4 reports |
| Purdue Pharma L.P. | Lobbied on it | Purdue Pharma L.P. named AB 2821 in 4 lobbying reports. | 4 reports |
| Takeda Pharmaceuticals America | Lobbied on it | Takeda Pharmaceuticals America named AB 2821 in 4 lobbying reports. | 4 reports |
| Talecris Biotherapeutics, Inc., A Wholly Owned Subsidiary of Grifols Inc. | Lobbied on it | Talecris Biotherapeutics, Inc., A Wholly Owned Subsidiary of Grifols Inc. named AB 2821 in 4 lobbying reports. | 4 reports |
| Edwards Lifesciences | Lobbied on it | Edwards Lifesciences named AB 2821 in 3 lobbying reports. | 3 reports |
| Drug marketing: gifts. | Source records | AB 2821 has an explicit source reference to Drug marketing: gifts.. | None |
In the news
Reporting about the selected subject. Articles are context and do not establish a connection on this map.
Loading coverage…